Fullerton tweaks bank group for $200m SGX IPO
Fullerton Health’s planned $200m IPO will no longer feature Morgan Stanley as one of the leads, leaving JP Morgan and UBS as the two banks handling the Singapore-bound listing.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts